<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02761083</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1506</org_study_id>
    <nct_id>NCT02761083</nct_id>
  </id_info>
  <brief_title>PMCF-study Using Novosyn® Quick Suture Material in Ophthalmic Surgery</brief_title>
  <acronym>OPHTHALNOQ</acronym>
  <official_title>Post-Marketing Clinical Follow-up (PMCF) Study in Ophthalmic Surgery to Evaluate the Safety and Efficacy of Novosyn® Quick Suture Material. A Multicenter Randomized, Active-controlled, Double-blinded, Prospective, Observational Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B.Braun Surgical SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to show that the performance of Novosyn® Quick suture material is
      comparable with standard suture material used in Ophthalmic surgery. In order to show that,
      various safety and efficacy parameters have been selected. The outcome regarding these
      parameters will be compared in 2 treatment groups. Active control group will receive Vicryl®
      Rapide and the treatment group Novosyn® Quick for ophthalmic surgery. It was decided to
      design this study as a randomized trial, because limited clinical evidence is available in
      the literature for the active control group (Vicryl® Rapide) which can be used for
      comparison. Eye operation will be randomly allocated on the left and right side (1:1) to both
      treatment groups.

      Patients undergoing elective, primary ophthalmic surgery (dacryocystorhinostomy, ectropion,
      entropion, ptosis, eyelid tumor resection, blepharoplasty)
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Comparator was not available in the planned setting
  </why_stopped>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound infection rate</measure>
    <time_frame>3 months</time_frame>
    <description>Wound infection (Surgical site infection, SSI) is defined according to the definition of the US Centres for Disease Control and Prevention (CDC).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Wound dehiscence</measure>
    <time_frame>until 3 months post-operatively</time_frame>
    <description>A dehiscence of the skin which needs surgical treatment with re-closure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Tissue reaction (inflammation)</measure>
    <time_frame>until 3 months after surgery</time_frame>
    <description>A tissue reaction (inflammation) due to the suture material</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Suture removal due to adverse events</measure>
    <time_frame>until 3 months post-operatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Re-suturing due to dehiscence</measure>
    <time_frame>until 3 months post-operatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulated frequency of adverse events</measure>
    <time_frame>until 3 months postoperatively</time_frame>
    <description>(edema, allergic reaction, ulceration, bleeding, granuloma, swelling, recurrence, reoperation, dry eyes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain (VAS)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Discomfort (VAS)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Scar formation (VAS)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction (VAS)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction (EQ-5D-5L)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cosmetic Result (VAS)</measure>
    <time_frame>until 3 months postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Handling of the suture</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Assessment of the handling of the suture material intra-operatively using a questionnaire including different dimensions (knot security, tensile strength, knot run down, tissue drag etc.) with 5 evaluations levels (excellent, very good, good, satisfied, poor).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Dacryocystorhinostomy</condition>
  <condition>Ectropion</condition>
  <condition>Entropion</condition>
  <condition>Ptosis</condition>
  <condition>Eyelid Tumor Resection</condition>
  <condition>Blepharoplasty</condition>
  <arm_group>
    <arm_group_label>Novosyn® Quick</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye surgery using suture material</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vicryl® Rapid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye surgery using suture material</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novosyn® Quick</intervention_name>
    <description>Eye surgery</description>
    <arm_group_label>Novosyn® Quick</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vicryl® Rapid</intervention_name>
    <description>Eye surgery</description>
    <arm_group_label>Vicryl® Rapid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing an elective, primary ophthalmic surgery for dacryocystorhinostomy,
             ectropion, entropion, ptosis, eyelid tumor resection, and blepharoplasty.

          -  Age ≥18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Emergency surgery

          -  Previous ophthalmic surgery on the same eye

          -  Known allergy or inflammation reaction to suture material similar to Vicryl® Rapide or
             Novosyn® Quíck in previous surgery.

          -  Cicatrisation base alterations

          -  Concomitant medication, that might affect wound healing (e.g. immunosuppression
             therapy, anti-diabetic drugs, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Can Misses</name>
      <address>
        <city>Ibiza</city>
        <state>Baleares</state>
        <zip>07800</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>June 9, 2016</last_update_submitted>
  <last_update_submitted_qc>June 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eye surgery</keyword>
  <keyword>Suture material</keyword>
  <keyword>Novosyn Quick</keyword>
  <keyword>Vicryl Rapid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Entropion</mesh_term>
    <mesh_term>Ectropion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

